Chambers USA recognized the firm as a “powerhouse in the capital markets space.”
Omeed A. Valipour is an associate in the Chicago office of Latham & Watkins.
Prior to joining Latham, Dr. Valipour was a summer associate in the firm’s Washington, D.C. and Chicago offices. He earned his JD from the University of Chicago Law School, where he worked on corporate matters for several Fortune 500 companies through the law school’s Corporate Lab.
Dr. Valipour earned his PharmD from University of California, San Diego, where his clinical and scientific research focused on neuropharmacology and pharmacological drug metabolite predictors of disease pathogenesis and drug responsiveness involving HMG-CoA reductase inhibitors. Dr. Valipour’s research incorporated a broad variety of techniques, including those used in cellular and molecular biology, physiology, and pharmacology. As a result of his graduate and undergraduate training, Dr. Valipour has robust experience in the areas of life sciences, pharmacology, and pharmaceutical sciences.